+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Selective Serotonin Reuptake Inhibitor"

From
Bipolar Disorder Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
Antidepressants Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Antidepressants Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
Schizophrenia Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Schizophrenia Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 185 Pages
  • Global
From
From
Clomipramine Market - Global Forecast 2025-2030 - Product Thumbnail Image

Clomipramine Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
Benzodiazepine Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Benzodiazepine Drugs Market - Global Strategic Business Report

  • Report
  • January 2026
  • 388 Pages
  • Global
From
Depression Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Depression Drugs Market - Global Strategic Business Report

  • Report
  • January 2026
  • 380 Pages
  • Global
From
From
From
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • January 2026
  • 174 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 380 Pages
  • Global
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Bipolar Disorder Drugs and Treatment Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Drugs and Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator

Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder. SSRIs work by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood and reduce symptoms of mental illness. SSRIs are generally considered to be safer and more effective than other types of antidepressants, and they are often prescribed as a first-line treatment for mental disorders. The SSRI market is highly competitive, with many pharmaceutical companies offering different brands of SSRIs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies have developed a wide range of SSRIs, including Prozac, Zoloft, Paxil, and Lexapro. Other companies, such as Mylan and Teva, also offer generic versions of SSRIs. Show Less Read more